Anti-Diabetic Drugs: Intro Flashcards

1
Q

What is diabetes?

A

Group of syndromes characterized by an elevation of fasting blood glucose caused by a relative or absolute deficiency in insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Type 1 diabetes is characterized by what?

A

Absolute deficiency of insulin by an autoimmune attack on the beta cells of the pancreas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Symptoms appear abruptly when 80-90% of the beta cells have been destroyed. At this point the pancreas fails to respond to ingestion of glucose, and insulin therapy is required to restore metabolic control and prevent?

A

Life- threatening ketoacidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Type 1 diabetics must therefore rely on what?

A

Exogenous Insulin injected SQ to control the hyperglycemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are HBA1c levels?

A

Reflect glucose levels over the preceding 2 to 3 months

–provides a measure of how well the treatment has normalized blood glucose in diabetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The occurrence of the type 2 diabetes is almost completely determined by genetic factors. Give an example of this?

A

All monozygotic twinships, the disease develops in both individuals
–disease does not involve viruses or autoimmune attacks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the progression of type 2 diabetes?

A

Progresses from an early asymptomatic stage with insulin resistance, to mild postprandial hyperglycemia to frank diabetes requiring drugs

  • -insulin levels are therefore high in the beginning but peripheral insulin resistance and increased hepatic production of glucose make insulin levels inadequate to normalize plasma glucose levels
  • -insulin production falls and therefore hyperglycemia develops.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the pharmacotherapy for type 2 DM?

A

Noninsulin hypoglycemic agents that act by different mechanisms

  • -increase insulin secretion by beta cells, increase insulin sensitivity or slow glucose absorption from the gut
  • -therefore most type 2 diabetic do not require exogenous insulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Insulin is a small protein with 51 AA arranged in 2 polypeptide chains connected by disulfide bonds. Synthesized as what?

A

Proinsulin where it is hydrolyzed into insulin and peptide C

  • -both are secreted by Beta cells of pancreas in equimolar amounts in response to insulin secretagogues.
  • -small amount of proinsulin is secreted as well
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Insulin is released from the beta cells at a low basal rate and at much higher rate in response to a variety of stimuli. The secretion of insulin is stimulated by?

A
  1. Glucose
  2. AA: ingestion of protein causes a transient rise in plasma AA levels, which induces insulin secretion
  3. Gastrointestinal Lumen: hormones produced by the GI tract in response to food intake and which stimulate insulin secretion are called incretins. Glucagon-like peptide 1 (GLP-1) and gastric inhibitory peptide (GIP) are incretins. Incretins account for the fact that the same amount of glucose given orally induces a much greater secretion of insulin than given IV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the mechanism of insulin secretion?

A

Hyperglycemia results in increased ATP levels which close ATP dependent K channels, leading to membrane depolarization and opening of voltage gate calcium channels. Influx of Ca2+ causes pulsatile insulin exocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Insulin is activated by what enzyme?

A

Insulinase

  • -found in the liver and kidney.
  • -60% of exogenous insulin is cleared by the kidney and 30-40% by the liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Insulin receptors bind insulin with high specificity and affinity in the picomolar range. The biologic responses promoted by these insulin receptor complexes have been identified in the primary target tissues..?

A

Liver
Muscle
Adipose Tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does the insulin receptor consist of?

A

Two convalently linked heterodimers

  • -each containing an alpha subunit which is extracellular and a beta subunit which spans the membrane
  • -the beta subunit contains a tyrosine kinase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the first proteins to be phosphorylated once the tyrosine kinase residues have been phosphorylated on the beta subunits?

A

Insulin receptor substrate protein (IRS)
–phosphorylated IRS proteins interact with other signaling molecules activating a number of pathways that ultimately affect gene expression, metabolism and growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the metabolic effect of insulin on carbohydrate metabolism?

A

Liver: inhibits gluconeogenesis and glycogenolysis and accelerates glycolysis and glycogen synthesis
Muscle: stimulates glycogen synthesis
Muscle and Adipose: increases glucose uptake by increasing the number of GLUT4 glucose transporters in the cell membrane. When insulin activates insulin receptors on these cells, the vesicles fuse with the plasma membrane; inserting the transporters into it. This leads to a rapid increase of the number of functional GLUT 4 transporters. Therefore insulin promotes uptake of glucose by muscle and fat.

17
Q

What are the metabolic effects of insulin on lipid metabolism?

A

Insulin inhibits hormone sensitive lipase in adipose tissue therefore leading to a decrease of circulating FA
Insulin increases synthesis of FA and TAGs and their storage in the adipose tissue
Insulin increases levels of lipoprotein lipase of adipose tissue, providing FA for esterification.

18
Q

What are the metabolic effects of insulin on protein synthesis?

A

Insulin stimulates entry of AA into cells and protein synthesis in most tissues.
Insulin promotes uptake of branched AA by muscle, consequently it leads to build up of muscle protein

19
Q

What is the source of insulin?

A

Human insulin produced by recombinant DNA technology using special strain of E. coli or yeast
–via modification of AA sequence of human insulin there are insulins with different pharmacokinetic properties

20
Q

Commercial insulin preparations differ in a number of ways, such as time of onset and duration of action. What are the four principal types of injected insulins?

A
  1. Rapid acting (fast onset with short duration)
  2. Short Acting (rapid onset of action)
  3. Intermediate Acting
  4. Long Acting (slow onset of action)
21
Q

There are three injected, rapid acting insulin analogs, what are they?

A
  1. Insulin Lispro
  2. Insulin Aspart
  3. Insulin Glulisine
    - -native insulin monomers are associated as hexamers and in currently available insulin preparations. These hexamers slow the absorption and reduce postprandial peaks of SQ injected insulin. These pharmacokinetics lead to the development of rapid acting insulin analogs that retain a monomeric configuration.
22
Q

First what are some aspects of Insulin Lispro (rapid acting)?

A

Differs from regular insulin in that lysine and proline at positions 28 and 29 in the B chain are reversed.
–dissociates into monomers and is absorbed very rapidly

23
Q

Second what are some aspects of Insulin Aspart (rapid acting)?

A

Created via substitution of the B28 proline by an aspartate

24
Q

Third what are some aspects of Insulin Glulisine (rapid acting)?

A

Formulated replacing asparagine by lysine at B3 and lysine by glutamate at B29

25
Q

What are some additional features of rapid acting insulins?

A

Administered to mimic the prandial release of insulin (given with a longer acting insulin to assure glucose control)
Should be injected 15 minutes before a meal (peak serum levels are seen at 30-90 minutes post injection and duration of action is 3-4 hours)
Provide greater control of postprandial plasma glucose and are associated with less risk of hypoglycemia episodes
Preferred for use in insulin pumps because they do not form hexamers

26
Q

Next are the short acting insulins, what are some features of short acting insulins?

A

Regular Insulin
Soluble crystalline zinc insulin
Should be given 30 minutes before a meal
Safe in pregos (long acting insulin can be used in pregos but is not preferred)

27
Q

Next up are the intermediate acting insulins. What are some features of the intermediate insulins?

A

Neutral Protamine Hagedorn (NPH)
—also called isophane insulin (crystalline zinc insulin combined with protamine)
Duration of Action: Intermediate due to delayed absorption of insulin due to conjugation of insulin with protamine to form a less soluble complex

28
Q

What is intermediate acting insulin used for?

A
Basal Control (usually given along with a rapid or short acting insulin for mealtime control) 
Variability of absorption is over 50% 
Clinical use of NPH insulin is waning due to adverse pharmacokinetics combined with the availability of long acting insulin analogs
29
Q

Finally the long acting Insulins, there are two, Insulin Glargine and Insulin Determir. First lets talk about Insulin Glargine. What are some features?

A

Two arginine residues are added to the C terminus of the B chain and asparagine residue in position A21 of the A chain is replaced by glycine.

  • -analog that is soluble in acidic solution but precipitates in neutral pH after SQ injection.
  • -depot is formed and a low, continuous level of circulating insulin is produced.
30
Q

How can Insulin Glargine be given?

A

Can not be mixed with short acting insulin preparations
–long acting have an acidic pH and short have a neutral pH
Given SID: sustained peakless absorption profile
Better once daily 24 hour insulin coverage and has a lower risk of hypoglycemia than NPH insulin

31
Q

The second long acting Insulin is Insulin Determir. What are some features?

A

Terminal threonine is removed from the B30 position and myristate is attached to the terminal B29 lysine.
–it has a lower risk of hypoglycemia than NPH insulin
Given BID